Venue
This year's event will be held at:
Revere Hotel Boston Common
200 Stuart Street, Boston, Massachusetts, 02116
USA
Important Note - Fraudulent Accommodation Booking Scams
We have been made aware that there are third-party companies contacting our conference attendees claiming to represent Hanson Wade Group with fraudulent hotel booking schemes.
Hanson Wade Group does not work with any third parties and accommodation information will only come directly from your Event Manager. For your safety, please only book your accommodation through official links provided by Hanson Wade Group. Learn more in our full accommodation policy: Accommodation Policy - Hanson Wade Group.
Explore the Agenda
Hear the latest breakthroughs in biomarker validation, surrogate endpoints, and clinical trial design through a packed agenda featuring, 3 expert panel discussions, 3 pre-conference workshops, 2 interactive roundtables, and 12+ data-driven case study presentations.
Partner With Us
Position yourself alongside leading solution providers supporting rare and genetic kidney disease pipelines. Whether your expertise lies in preclinical or clinical research, novel biomarkers for diagnosis, stratification or monitoring, imaging, or genetic testing, ensure your brand is at the center of key conversations around clinical development, endpoint validation, and trial execution
Join Biopharma Experts
Engage with a uniquely focused audience of rare and genetic kidney disease decision-makers and be part of high-value conversations with like-minded attendees across all stages of drug development, building critical connections through dedicated networking opportunities